Ophthalmology · Seguin, TX
NPI
1992718373
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
128 S Moss St, Ste 300
Seguin, TX, 78155
Phone (830) 379-3937
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
13,555 services
Medicare patients, 2024
2,110
Average age 75
Drug cost, 2024
$1.8M
10,513 prescriptions
Company payments, 2025
$15K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph T Kavanagh was code 99214 (office e&m - established), 2,378 times for 1,633 patients. In total Joseph T Kavanagh billed 13,555 services in 68 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,378 | 1,633 | $80.95 | $192K |
| 92202 Ophthalmological E&M | Office | 2,084 | 1,653 | $10.29 | $21K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,995 | 1,604 | $25.61 | $51K |
| 92136 Ultrasound - Nonspecific | Office | 1,019 | 359 | $17.17 | $17K |
| 68761 Eye | Office | 665 | 516 | $151.28 | $101K |
| 92083 Vision, Hearing, and Speech Services | Office | 541 | 517 | $42.32 | $23K |
| 66984 Cataract Surgery | Facility | 488 | 298 | $361.17 | $176K |
| 99213 Office E&M - Established | Office | 477 | 348 | $61.10 | $29K |
| 92133 Computerized Ophthalmic Imaging | Office | 388 | 362 | $22.56 | $8,754 |
| 99204 Office E&M - New | Office | 378 | 378 | $102.96 | $39K |
| 92273 Test - Miscellaneous | Office | 349 | 344 | $85.70 | $30K |
| 92250 Angiography | Office | 321 | 305 | $24.31 | $7,805 |
| J7351 Injection, bimatoprost, intracameral implant, 1 microgram | Office | 320 | 21 | $163.22 | $52K |
| 65778 Eye | Office | 306 | 209 | $793.90 | $243K |
| 66821 Cataract Surgery | Office | 227 | 198 | $242.91 | $55K |
By year: 2022 $1.3M for 13,024 services; 2023 $1.2M for 13,179 services; 2024 $1.3M for 13,555 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 155 | 75 | $22.03 | $3,415 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph T Kavanagh prescribed most often to Medicare patients was Latanoprost, with 2,352 prescriptions and refills. In total Joseph T Kavanagh wrote 10,513 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,352 | 4,891 | 745 | $25K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 1,444 | 1,465 | 911 | $64K |
| Diclofenac Sodium Generic | 1,286 | 1,313 | 686 | $15K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 576 | 1,178 | 170 | $9,164 |
| Restasis Cyclosporine | 504 | 1,040 | 222 | $637K |
| Timolol Maleate Generic | 495 | 937 | 151 | $9,515 |
| Prednisolone Acetate Generic | 405 | 481 | 280 | $14K |
| Brimonidine Tartrate Generic | 320 | 575 | 91 | $6,369 |
| Cyclosporine Generic | 260 | 426 | 109 | $124K |
| Dorzolamide Hcl Generic | 234 | 422 | 63 | $4,029 |
| Tobradex St Tobramycin/Dexamethasone | 224 | 227 | 143 | $53K |
| Xiidra Lifitegrast | 204 | 424 | 71 | $281K |
| Lumigan Bimatoprost | 176 | 326 | 57 | $86K |
| Ofloxacin Generic | 161 | 164 | 117 | $1,894 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 158 | 197 | 35 | $67K |
Brand drugs: 3,670 claims; generic drugs: 6,843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph T Kavanagh $15K ($15K in general payments such as food, travel and fees) from 15 companies. The largest payer was Glaukos Corporation with $6,505.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 4 | $6,505 |
| Ocular Therapeutix, Inc. OCUL | 7 | $5,900 |
| Amgen Inc. AMGN | 6 | $393 |
| Alcon Vision LLC ALC | 3 | $327 |
| Abbvie Inc. ABBV | 17 | $314 |
| Bausch & Lomb Americas Inc. BLCO | 7 | $297 |
| Biotissue Holdings Inc. | 2 | $237 |
| Tarsus Pharmaceuticals, Inc. TARS | 7 | $222 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 7 | $181 |
| Sight Sciences, Inc. SGHT | 1 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.